Intestinal microbiota, probiotics and human gastrointestinal cancers (Q38062446)

28 August 2017

1 reference

retracted paper

2 references

Dataset for "Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine"

Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine

title

Intestinal microbiota, probiotics and human gastrointestinal cancers (English)

1 reference

28 August 2017

0 references

Antonella Orlando

1

1 reference

PubMed ID

23180023

28 August 2017

Francesco Russo

series ordinal

2

1 reference

PubMed ID

23180023

28 August 2017

language of work or name

1 reference

1 June 2013

1 reference

Journal of gastrointestinal cancer

28 August 2017

1 reference

28 August 2017

44

1 reference

28 August 2017

2

1 reference

28 August 2017

121-131

1 reference

https://scigraph.springernature.com/pub.10.1007/s12029-012-9459-1

28 August 2017

0 references

cites work

The role of gut microbiota (commensal bacteria) and the mucosal barrier in the pathogenesis of inflammatory and autoimmune diseases and cancer: contribution of germ-free and gnotobiotic animal models of human diseases

1 reference

https://api.crossref.org/works/10.1007%2FS12029-012-9459-1

Enteric flora in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-012-9459-1

A gastroenterologist's guide to probiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-012-9459-1

Helicobacter pylori in gastric malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-012-9459-1

Gastric cancer: basic aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-012-9459-1

Helicobacter pylori and gastric cancer: factors that modulate disease risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-012-9459-1

Helicobacter pylori infection causes gastric cancer? A review of the epidemiological, meta-analytic, and experimental evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-012-9459-1

Migrant communities constitute a possible target population for primary prevention of Helicobacter pylori-related complications in low incidence countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-012-9459-1

Helicobacter pylori infection in young patients with gastric carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-012-9459-1

Review article: common misconceptions in the management of Helicobacter pylori-associated gastric MALT-lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-012-9459-1

Mechanisms of disease: Helicobacter pylori-related gastric carcinogenesis--implications for chemoprevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-012-9459-1

Dietary factors and stomach cancer mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-012-9459-1

Dietary salt, nitrate and stomach cancer mortality in 24 countries. European Cancer Prevention (ECP) and the INTERSALT Cooperative Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-012-9459-1

Effect of physiological concentrations of vitamin C on gastric cancer cells and Helicobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-012-9459-1

Treatment of pancreatic adenocarcinoma: a European perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-012-9459-1

21 January 2018

Probiotics in surgery

1 reference

https://api.crossref.org/works/10.1007%2FS12029-012-9459-1

Genetics, inheritance and strategies for prevention in populations at high risk of colorectal cancer (CRC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-012-9459-1

Concepts in familial colorectal cancer: where do we stand and what is the future?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-012-9459-1

Review article: nutrition, obesity and colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-012-9459-1

Prevention of colorectal cancer: diet, chemoprevention, and lifestyle

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-012-9459-1

Dietary patterns and the risk of colorectal cancer and adenomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-012-9459-1

Colorectal cancer in patients with inflammatory bowel disease: can we predict risk?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-012-9459-1

Microbial dysbiosis in colorectal cancer (CRC) patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-012-9459-1

Molecular characterization of mucosal adherent bacteria and associations with colorectal adenomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-012-9459-1

Categorization of the gut microbiota: enterotypes or gradients?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-012-9459-1

Microbial culturomics: paradigm shift in the human gut microbiome study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-012-9459-1

Human gut microbiota: dysbiosis and manipulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-012-9459-1

Ecological and evolutionary forces shaping microbial diversity in the human intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-012-9459-1

Diversity, stability and resilience of the human gut microbiota

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-012-9459-1

Probiotic bacteria and intestinal epithelial barrier function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-012-9459-1

Overview of gut immunology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-012-9459-1

'Gut health': a new objective in medicine?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-012-9459-1

Targeting the human microbiome with antibiotics, probiotics, and prebiotics: gastroenterology enters the metagenomics era

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-012-9459-1

The gut microbiota shapes intestinal immune responses during health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-012-9459-1

Functional and comparative metagenomic analysis of bile salt hydrolase activity in the human gut microbiome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-012-9459-1

An obesity-associated gut microbiome with increased capacity for energy harvest

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-012-9459-1

PROBIOTICS: GROWTH-PROMOTING FACTORS PRODUCED BY MICROORGANISMS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-012-9459-1

Mechanisms of action of probiotics: recent advances

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-012-9459-1

Role of erythropoietin in cancer-related anaemia: a double-edged sword?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-012-9459-1

The impact of pre- and/or probiotics on human colonic metabolism: does it affect human health?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-012-9459-1

Cancer-preventing attributes of probiotics: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-012-9459-1

Role of probiotics, prebiotics and synbiotics in chemoprevention for colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-012-9459-1

The effect of selected synbiotics on microbial composition and short-chain fatty acid production in a model system of the human colon

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-012-9459-1

Intestinal immunity of rats with colon cancer is modulated by oligofructose-enriched inulin combined with Lactobacillus rhamnosus and Bifidobacterium lactis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-012-9459-1

Modulation of the intestinal microbiota alters colitis-associated colorectal cancer susceptibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-012-9459-1

Comparison of four microbial enzymes in Clostridia and Bacteroides isolated from human feces

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-012-9459-1

Effect of Lactobacillus acidophilus KFRI342 on the development of chemically induced precancerous growths in the rat colon.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-012-9459-1

Bacteriocins from lactic acid bacteria: production, purification, and food applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-012-9459-1

Use of HT-29, a cultured human colon cancer cell line, to study the effect of fermented milks on colon cancer cell growth and differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-012-9459-1

Antiproliferative effect of fermented milk on the growth of a human breast cancer cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-012-9459-1

Effect of intestinal bacteria on formation of azoxymethane-induced aberrant crypt foci in the rat colon.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-012-9459-1

Temporal gene expression and probiotic attributes of Lactobacillus acidophilus during growth in milk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-012-9459-1

Adhesion of probiotic strains to the intestinal mucosa and interaction with pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-012-9459-1

The front line of enteric host defense against unwelcome intrusion of harmful microorganisms: mucins, antimicrobial peptides, and microbiota

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-012-9459-1

Interaction of probiotic Lactobacillus and Bifidobacterium strains with human intestinal epithelial cells: adhesion properties, competition against enteropathogens and modulation of IL-8 production.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-012-9459-1

Specific probiotic strains and their combinations counteract adhesion of Enterobacter sakazakii to intestinal mucus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-012-9459-1

Exopolysaccharides produced by probiotic strains modify the adhesion of probiotics and enteropathogens to human intestinal mucus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-012-9459-1

Immunomodulation by treatment with Lactobacillus casei strain Shirota

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-012-9459-1

Distinct immune response induced by peptidoglycan derived from Lactobacillus sp

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-012-9459-1

Roles of probiotics and prebiotics in colon cancer prevention: Postulated mechanisms and in-vivo evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-012-9459-1

Cytochromes P450, drugs, and diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-012-9459-1

Effects of Lactobacillus rhamnosus GG on proliferation and polyamine metabolism in HGC-27 human gastric and DLD-1 colonic cancer cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-012-9459-1

Lactobacillus rhamnosus GG influences polyamine metabolism in HGC-27 gastric cancer cell line: a strategy toward nutritional approach to chemoprevention of gastric cance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-012-9459-1

Programmed cell death pathways in cancer: a review of apoptosis, autophagy and programmed necrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-012-9459-1

Targeted manipulation of apoptosis in cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-012-9459-1

Antiproliferative and proapoptotic effects of viable or heat-killed Lactobacillus paracasei IMPC2.1 and Lactobacillus rhamnosus GG in HGC-27 gastric and DLD-1 colon cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-012-9459-1

Adherence and anticarcinogenic effects of Bacillus polyfermenticus SCD in the large intestine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-012-9459-1

The influence of Lactobacillus brevis on ornithine decarboxylase activity and polyamine profiles in Helicobacter pylori-infected gastric mucosa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-012-9459-1

The effect of probiotics on Helicobacter pylori eradication.

21 January 2018

1 reference

12 December 2020

Strain- and matrix-dependent adhesion of Lactobacillus plantarum is mediated by proteinaceous bacterial compounds

1 reference

12 December 2020

Chemoprevention in gastrointestinal adenocarcinoma: for few but not for all?

1 reference

12 December 2020

Commensal bacteria and "oncologic surveillance": suggestions from an experimental model

1 reference

12 December 2020

Association of helicobacter pylori infection and colon cancer

1 reference

12 December 2020

A new morphologically characterized cell wall preparation (whole peptidoglycan) from Bifidobacterium infantis with a higher efficacy on the regression of an established tumor in mice.

1 reference

12 December 2020

Progression of precancerous gastric lesions

1 reference

12 December 2020

Dietary synbiotics reduce cancer risk factors in polypectomized and colon cancer patients

1 reference

12 December 2020

Probiotics in clinical practice: an overview

1 reference

12 December 2020

Pan-fried meat containing high levels of heterocyclic aromatic amines but low levels of polycyclic aromatic hydrocarbons induces cytochrome P4501A2 activity in humans

1 reference

12 December 2020

Effects of anandamide on polyamine levels and cell growth in human colon cancer cells.

1 reference

12 December 2020

Streptococcus bovis isolated in haemoculture a signal of malignant lesion of the colon.

1 reference

12 December 2020

High-salt diet induces gastric epithelial hyperplasia and parietal cell loss, and enhances Helicobacter pylori colonization in C57BL/6 mice.

1 reference

12 December 2020

Prevention of colon cancer by pre- and probiotics: evidence from laboratory studies

1 reference

12 December 2020

Polyamines, diamine oxidase, and ornithine decarboxylase activity in colorectal cancer and in normal surrounding mucosa

1 reference

12 December 2020

A diet high in fruits and low in meats reduces the risk of colorectal adenomas

1 reference

12 December 2020

Human squamous cell carcinoma of the tongue and colon undergoes apoptosis upon phagocytosis of Saccharomyces cerevisiae, the baker's yeast, in vitro

1 reference

12 December 2020

Effects of probiotic bacteria (VSL#3) on the polyamine biosynthesis and cell proliferation of normal colonic mucosa of rats.

1 reference

12 December 2020

Immunomodulatory and antitumor effects in vivo by the cytoplasmic fraction of Lactobacillus casei and Bifidobacterium longum.

1 reference

12 December 2020

Epigenetic mechanisms underlying diet-sourced compounds in the prevention and treatment of gastrointestinal cancer

1 reference

12 December 2020

Probiotics prevent the development of 1,2-dimethylhydrazine (DMH)-induced colonic tumorigenesis through suppressed colonic mucosa cellular proliferation and increased stimulation of macrophages

1 reference

12 December 2020

Inhibition of proliferation in colon cancer cell lines and harmful enzyme activity of colon bacteria by Bifidobacterium adolescentis SPM0212

1 reference

12 December 2020

Evidence for probiotic potential of a capsular-producing Streptococcus thermophilus CHCC 3534 strain.

1 reference

12 December 2020

Induction of apoptosis in breast cancer cells by Saccharomyces cerevisiae, the baker's yeast, in vitro

1 reference

12 December 2020

The effect of a probiotic drink with Lactobacillus plantarum 299v on the bacterial composition in faeces and mucosal biopsies of rectum and ascending colon

1 reference

12 December 2020

Interaction analyses of human monocytes co-cultured with different forms of Aspergillus fumigatus

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1007/S12029-012-9459-1

Identifiers

DOI

10.1007/S12029-012-9459-1

1 reference

28 August 2017

1 reference

PubMed ID

23180023